) and a non-MCH, hypothalamic (arcuate) marker gene (Agrp) after IPs from the hypothalamus of Pmch-Cre mice using vTRAP (black bars) or crossed to the Rosa26 fsTRAP reporter (gray bars). (C) Quantitative RT-PCR comparison (Mean+SEM) of a non-MCH neuron, midbrain marker gene (Anxa1), and newly-identified MCH neuron marker genes (Crhbp, Dmrtb1, Mup6) after IPs from the hypothalamus using vTRAP (black bars) or Rosa26 fsTRAP reporter (gray bars). All data are displayed as mean ± SEM. ND, the IP RNA was not detected. (C) Low magnification image of EGFP (green) and NeuN (blue) immunofluorescence from a brain of a Ntsr1-Cre mouse that received an injection of AAV-FLEX-EGFPL10a into somatosensory cortex. EGFP expression can be seen in the cell bodies in the cortex (arrows) as well as the axon terminal fields in the thalamus (arrowheads). Image was taken from a composite of a tiled scan of a coronal brain slice. CPu, caudate-putamen; Hip, hippocampus; ic, internal capsule; VPL/M, ventral posterolateral and ventral posteromedial nuclei of thalamus. Scale bar, 250 µm.
(D) Left panel shows a higher magnification of the boxed area in C and the right panel is the equivalent region from a Ntsr1-bacTRAP mouse. Note the visible EGFP expression in the axon terminal fields of a Cre mouse injected with the AAV-FLEX-EGFPL10a virus (arrowheads) but not in the bacTRAP mouse. ic, internal capsule; Rt, reticular thalamic nucleus; VPL/M, ventral posterolateral and ventral posteromedial nuclei of thalamus. Scale bar, 250 µm. (E) Low magnification image of anti-EGFP immunofluorescence in cortex from an Abcb1a-bacTRAP ES3026 mouse. CA1, CA1 field of hippocampal formation; cc, corpus collosum; m, midline; p, pial surface. Scale bar, 500 µm. (F) Higher magnification image of cortex of Abcb1a-bacTRAP mouse showing co-labeling of anti-EGFP (green) with andti-CD31, an endothelial cell marker (Pecam1, red). Scale bar, 100 µm. (A) Scatter plots comparing the normalized counts of all genes between individual replicate IPs from bacTRAP and vTRAP samples from AAV2, AAV5, and AAV9. The coefficient of determination (r 2 ) for each comparison is displayed in the top left corner. (B) Venn diagrams indicating the number of genes significantly enriched in the TRAP IP (purple), the number of genes significantly depleted from the IPs (gray) and the number of genes not enriched or depleted in the bacTRAP and vTRAP experiments. Total number of genes with mapped reads in each experiment is in italics at the bottom. (C) ABA ISH showing the cortex expression of neuronal genes Foxp2 (layer 6, coronal), Syt6 (layer 6, coronal), Tmem200a (layer 5, coronal), and the oligodendroglia marker, Mal (sagittal). Scale bars, 500 µm. (A) The top 1000 highest expressed genes were identified for three published single cell RNA-seq data sets comprised of layer 6 pyramidal cell populations: "L6a Mgp," "L6a Sla," (Tasic 2016) and "S1Pyr6" (Zeisel 2015) . For each gene, the fold change was determined in the AAV9 vTRAP IP over input and the proportion of genes highly enriched (dark blue), enriched (light blue), expressed (not strongly enriched or depleted, gray), depleted (light red), or highly depleted (dark red) were plotted in a stacked bar graph. The fold change cutoff for each category is indicated on the right (vTRAP FC). More than 75% of the genes on each data set had a fold change >1.0 (over 92% of the genes from each data set were in the "expressed" range or higher) with over 45% being enriched greater than 1.3-fold in the IPs, demonstrating the sensitivity of vTRAP. (B) Scatter plot of vTRAP IP (x-axis) and whole cortex input (y-axis) normalized counts for the top 1000 genes expressed in the L6a Mgp single cell data set. Genes are colored based on vTRAP fold change bins as in A. Dotted lines show 2-fold enrichment and depletion and solid gray line indicates the origin. Dashed blue line shows -1.3-fold change, with "expressed" genes found to the right of the line. (C) vTRAP enriched genes (log 2 FC>1) were ranked based on their expression (log 10 RPKM) from highest to lowest (left to right) expression values were plotted for vTRAP IPs (black circles) and bacTRAP IPs (gray circles). The bar at the bottom indicates genes where RPKM=0 (not detected, ND). The bacTRAP expression values correlate very highly with those of vTRAP, with only three lowexpressed genes failing to be detected by bacTRAP. (D) vTRAP enriched genes are plotted as in C with the expression values from three single cell data sets (L6a Mgp, blue; L6a Sla, green; S1Pyr6, red). The comparative expression for each gene was much more variable compared to bacTRAP (C), and many lowexpressed genes in the vTRAP data were not detected in the single cell samples. (E) Low expressed vTRAP genes were binned based on expression and the percent of genes in each bin with RPKM=0 in bacTRAP and single cell data sets was quantified. The total number of genes in each bin is indicated at the top and the number of genes not detected is written above each bar. Table S2 . Ntsr1-Specific Genes, Related to Figure 5 . The Specificity Index algorithm (Dougherty et al., 2010) was used to generate a list of genes specific for Ntsr1-expressing neurons compared to other cell types in the cortex (see Supplementary Table 1 ). The rank of each gene in each cell type and pSI is indicated. (Table is attached at the end of this document.) Table S3 . Previously identified cell type specific genes, Related to Figure 5 . This table contains a compiled list of genes that were previously shown to label L6 projection neurons or glial cells by a variety of distinct methodologies. The log2 fold change (TRAP IP/input) of each gene is shown for each replicate of bacTRAP and vTRAP data sets. In addition, a summary of the methodology used, the cell type ID, and a hyperlink to the original source are also included. Genes appearing multiple times on the list are shown in bold. For glial genes, only the top 10 genes from each study are listed for each cell type. (Table is attached at the end of this document.) 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Animals
All procedures involving animals were approved by The Rockefeller University Institutional Animal Care and Use Committee and were in accordance with National Institutes of Health guidelines. Ntsr1-bacTRAP (TS16), Pmch-Cre, and DAT-Cre mice were generated and maintained at The Rockefeller University and described previously (Doyle et al., 2008; Ekstrand et al., 2014; Jego et al., 2013; Knight et al., 2012) . Ntsr1-Cre (GN220) and SERT-Cre (ET33) mice were generated by the GENSAT Project (Gong et al., 2007) and were purchased from the Mutant Mouse Regional Resource Center (Stock IDs 017266-UCD and 031028-UCD, respectively). Rosa26 tdTomato (Stock #007914) and Rosa26 fsTRAP (Stock #022367) mice were purchased from The Jackson Laboratories. All mice were bred on a C57BL/6J background and maintained on a 12 hr light-dark cycle. Animals used in the study were male and female. Mice were sacrificed at 10-20 weeks of age within the same circadian period (12:00-16:00).
To generate the Abcb1a-bacTRAP mice, the RP24-384G12 BAC, which contained the Abcb1a locus, was modified using the two-plasmid/one recombination protocol as described previously (Gong et al., 2010; Gong et al., 2002) . Briefly, a homology arm corresponding to the region immediately upstream of the ATG translation initiation site of the Abcb1a gene was cloned into the pS296 targeting vector (Heiman et al., 2008) containing EGFPL10a using the AscI and NotI restriction sites. Recombination was performed by electroporating the pS296-Abcb1a vector into electrocompetent DH10β bacteria containing pSV1.RecA plasmid and the BAC. Successful recombination was determined by screening cointegrates by PCR and Southern blot analysis of HindIII digested BAC DNA, using the homology region as a probe. The modified BAC was prepared by double acetate purification with CsCl centrifugation followed by membrane dialysis and microinjected into the pronuclei of fertilized FVB/N mouse oocytes at a concentration of 0.5 ng/µl. Six transgenic founder mice were generated and crossed to C57BL/6J mice. F1 progeny were screened for proper transgene expression by EGFP immunohistochemistry. Founder line ES3026 showed accurate and robust expression of the transgene and was therefore selected for colony expansion.
Generation of AAVs
The plasmid pAAV-FLEX-EGFPL10a was generated in an analogous fashion to pAAV-FLEX-NBL10 (Ekstrand et al., 2014) . Briefly, the EGFPL10a transgene was PCR amplified from the pS296 targeting vector (Heiman et al., 2008) adding 5' NheI and 3' AscI restriction sites. The amplicon was then subcloned into pAAV-EF1a-DIO-hChR2 (H134R)-mCherry-WPRE-HGHpA (Addgene plasmid #20297) in the reverse orientation using NheI and AscI sites, replacing ChR2-mCherry, to create pAAV-FLEX-EGFPL10a. Plasmids were then packaged into AAVs serotyped with AAV5 capsids at the University of North Carolina Vector Core or AAV2 and AAV9 capsids at the University of Pennsylvania Vector Core. Virus titers were 1.63x10 13 gc/ml for AAV5, 4.7x10 12 gc/ml for AAV2, and 7.47x10 12 gc/ml for AAV9.
Stereotaxic Surgeries
Surgeries were performed on adult mice (8-20 weeks old) under ketamine/xylazine (100/10 mg/kg) anesthesia. Single bilateral stereotaxic injections of 0.25-1.0 µl pAAV-FLEX-EGFPL10a were done using the following injection sites: DRN, +0.8 mm ML, 0 mm AP from lambda, -3.0 mm DV from dura, injected at a 15° angle; VTA ± 1.0 ML, -3.15 AP from bregma, -4.23 DV from dura, injected at a 7°angle; LH ±1.56 ML, -1.2 AP from bregma, -4.75 DV, injected at a 8° angle; S1BF, +2.5 ML, -1.0 AP from bregma, -0.75 DV from dura. For S1BF injections, a single bilateral injection of 0.25 µl virus into S1BF was done for each serotype. Following injections, the needle was slowly retracted and skin was closed with a surgical clip. Animals were sacrificed 3-4 weeks after surgery and tissue was collected for polysome immmunoprecipitations or immunohistology as described. For polysome fractionation experiments, 0.3 µl AAV9 pseudotyped pAAV-FLEX-EGFPL10a virus was bilaterally injected into S1BF at three sites spaced 0.2 mm apart in the AP plane of Emx1-Cre mice. Mice were sacrificed for polysome biochemistry either one week or four weeks after surgery (see below).
Immunohistochemistry
Mice were deeply anesthetized and transcardially perfused with PBS followed by 4% paraformaldehyde in PBS. Brains were dissected and postfixed for 8-12 hours at 4°C, cryopreserved in 30% sucrose solution, and sectioned on a freezing microtome (35 µm sections). Free-floating sections were immunofluorescently stained with chicken anti-GFP (1:2000, Abcam, Cambridge, MA, Cat# ab13970), mouse anti-NeuN (1:1000, Millipore, Billerica, MA, Cat# MAB377B), anti-TH (1:1000, Pel-Freez, Rogers, AR), anti-TPH2 (1:500, Novus Biologicals, Littleton, CO, Cat# NB100-74555), and anti-MCH (1:1000, Phoenix Pharmaceuticals, Berlingame, CA) primary antibodies. Sections were blocked for 60 min in PBS containing 2.5% normal goat serum (NGS) and 0.1% Triton-X-100 and then incubated overnight at 4°C with primary antibodies diluted in PBS containing 11% NGS and 0.1% Triton-X-100. Sections were washed with PBS and incubated for one hour at room temperature with Alexa-fluor conjugated secondary antibodies (Life Technologies, Waltham, MA) diluted in PBS. All sections were imaged on either a Zeiss LSM780 or LSM700 confocal microscope. For cell culture experiments, HEK293T cells were co-transfected with pAAV-FLEX-EGFPL10a and pCAG-Cre (Addgene plasmid #13775) using the Fugene-6 transfection method (Roche Diagnostics, Indianapolis, IN). After 36 hours, cells were fixed with 4% paraformaldehyde in PBS and visualized by immunofluorescent staining with chicken anti-GFP (as above) and mouse anti-c-Myc clone 9E10 (1:1000, Sigma-Aldrich, St. Louis, MO, Cat# M5546) primary antibodies followed by Alexa Fluor-488-conjugated goat anti-chicken and Alexa Fluor-568-conjugated goat anti-mouse secondary antibodies. Cells were then coverslipped and imaged on a Zeiss LSM700 confocal microscope.
Translating ribosome affinity purification
Affinity purification of EGFP-tagged polysomes was carried out as previously described (Heiman et al., 2014) . IPs were done 3-4 weeks after viral injections and three biological replicates consisting of brain tissue pooled from 3-5 mice (male and female) were used for each condition. Mice were sacrificed, followed by rapid dissection of brain tissue in ice-cold HBSS containing 2.5 mM HEPES-KOH (pH 7.4), 35 mM glucose, 4 mM NaHCO 3 , and 100 µg/ml cycloheximide. Tissue containing relevant brain regions (e.g. whole cortex, hypothalamus) was then homogenized in extraction buffer containing 10 mM HEPES-KOH (pH 7.4), 150 mM KCl, 5 mM MgCl 2 , 0.5 mM DTT, 100 µg/ml cycloheximide, RNasin (Promega, Madison, WI) and SUPERas-In TM (Life Technologies) RNase inhibitors, and Complete-EDTA-free protease inhibitors (Roche), and then cleared by centrifugation at 2000 x g. IGEPAL CA-630 (NP-40, Sigma) and DHPC (Avanti Polar Lipids, Alabaster, AL) were both added to the S2 supernatant to a final concentration of 1% for each, followed by centrifugation at 20,000 x g. Polysomes were immunoprecipitated from the S20 supernatant using 100 µg monoclonal anti-EGFP antibodies (50 µg each of clones 19C8 and 19F7; see Heiman et al., 2008) bound to biotinylated-Protein L (Pierce, Thermo Fisher, Waltham, MA) coated streptavidin-conjugated magnetic beads (Life Technologies), and washed in high salt buffer containing 10 mM HEPES-KOH (pH7.4), 350 mM KCl, 5 mM MgCl 2 , 1% IGEPAL CA-630, 0.5 mM DTT, 100 µg/ml cycloheximide, and RNasin RNase inhibitors (Promega). IPs were carried out overnight at 4°C. Bound RNA was purified using the Absolutely RNA Nanoprep kit (Agilent, Santa Clara, CA). RNA was also purified from a fraction of the pre-IP S20 supernatant to serve as whole-tissue "input" samples. RNA quantity was measured with a Nanodrop 1000 spectrophotometer and quality was assayed on an Agilent 2100 Bioanalyzer. Only samples with RNA integrity values >7.0 were used for RNA-seq and qRT-PCR analyses.
RNA-seq
For cortical samples, 15 ng of total RNA was amplified using the Ovation RNA-Seq System V2 Kit (NuGEN, San Carlos, CA) and RNA-seq libraries were prepared from 10 µg amplified RNA using the TruSeq RNA Sample Preparation Kit v2 (Illumina, San Diego, CA) following manufacturer's protocols. MCH neuron RNA-seq libraries were prepared with oligo-dT priming using the SMARTer Ultra Low RNA Kit (Clontech, Mountain View, CA). Sequencing reactions (50 b.p., single end for all Ntsr1 samples, and 100 b.p., single end for MCH samples) were done using the Illumina HiSeq 2500 platform with three samples multiplexed per sequencing lane. RNA-seq read quality was assessed with FASTX Toolkit 0.0.13 and sequences were trimmed for trailing adaptors. Trimmed reads were then aligned to annotated exons using the mm10 mouse reference genome with STAR (Dobin et al., 2013) version 2.0.0e_r291 using default settings. The numbers of raw and mapped reads for each sample are presented in the table "Quality Control of RNA-seq Alignments" below. Quantification of aligned reads was done using the htseq-count module of the HTSeq framework (Anders et al., 2015) version 0.6.0 using the "union" mode with default settings to generate raw counts for each sample. Differential expression was calculated by DESeq2 (Love et al., 2014) version 1.4.5 using default settings and filtering for an FDR cutoff of <0.05 and |log 2 | fold change >1.0. For scatter plots ( Figures 3D, 4B , 5C, 6A, and S5B), data are displayed as log 2 mean of raw counts normalized to sample size for each sample ("normalized counts") as calculated by DESeq2. For specificity index analysis of multiple distinct cell types, cell specific gene expression quantification was carried out on DESeq2 normalized TRAP-seq counts using the pSI (Specificity Index Statistic) R-package version 1.1 (Dougherty et al., 2010) . For Figures 3C and E, RNA-seq data were normalized as fragments per kilobase of transcript per million mapped reads (FPKM) using Cufflinks v2.1.1. Fold-enrichment was calculated as FPKM of GFP IP divided by FPKM Input (IP/Input). RPKMs in Figure S5C and D were calculated as: RPKM = (10 9 * Count)/(Library Size * Gene Length), with Gene Length being the maximum sum of annotated exon lengths of gene transcripts for a given gene (based on GENCODE VM9 [Ensembl 84], updated March 14, 2016) . RNA-seq data sets have been deposited in NCBI's Gene Expression Omnibus (GEO; Barret et al., 2013) , and are accessible through GEO Series accession number GSE89737.
For comparison of vTRAP to single cell RNA-seq results in Figure S5 , raw sequence read archives (SRAs) of published single cell RNA-seq data were downloaded from NCBI's GEO. Data sets from GEO: GSE71585 representing six individual "Core" cells from Primary Type Cells "L6a Sla" (Cell ID T02251526, GEO: GSM1839921; T01101413, GEO: GSM1839898; T02271422, GEO: GSM1839927; T01101411, GEO: GSM1839896; T07011417, GEO: GSM1839960; and T07011415, GEO: GSM1839958) and "L6a Mgp" (T07011423, GEO: GSM1839966; T05151410, GEO: GSM1839939; T05151405, GEO: GSM1839934; T02251501, GEO: GSM1839902; T01101410, GEO: GSM1839895; T02271423, GEO: GSM1839928) were randomly selected for analysis (Tasic et al., 2016) . Six data sets from GEO: GSE60361 representing "S1Pyr6" cells (Zeisel et al., 2015) were selected based on their expression of the cell-type markers Rprm, Foxp2, and Syt6 (1772071041_E04, GEO: GSM1477180; 1772071040_F06, GEO: GSM1477141; 1772067073_G04, GEO: GSM1476683; 1772067074_C04, GEO: GSM1476697; 1772067074_G06, GEO: GSM1476721; 1772067064_A11, GEO: GSM1476528). All raw sequencing data sets were processed as described above. 
